Respiratory Syncytial Virus (RSV)
RSV is a prevalent respiratory virus that often manifests with cold-like symptoms. While many recover within a week or two, it's important to note that RSV can pose serious health risks, especially for infants and older adults, who are more susceptible to severe RSV and may require hospitalization.
Fortunately, vaccines provide a crucial shield against severe RSV for older adults. Additionally, there are monoclonal antibody products available to safeguard infants and young children from the potentially severe consequences of RSV. Explore this page to gain a deeper understanding of RSV infection and the importance of vaccination. The AMA provides informative articles and updates to keep you informed about the latest developments in RSV infection and vaccines.
